Breast Cancer

A recent study evaluated the safety and efficacy of a biosimilar to trastuzumab for the treatment of early stage breast cancer.

The first combination pack for the treatment of advanced or metastatic breast cancer in postmenopausal women has been approved by the FDA.

Metformin use has been suggested to improve outcomes for women with diabetes and breast cancer.

The FDA converted Ibrance to regular FDA approval and approved a supplemental New Drug Application for the drug, broadening its range of antihormonal therapy.

The FDA approved ribociclib, taken with an aromatase inhibitor, for the treatment of advanced or metastatic breast cancer in post-menopause women.

In a recent study, researchers examined whether a compound found in soy, isoflavone, could potentially reduce all-cause mortality risk in breast cancer survivors.

A recent study investigated whether an adolescent and early adulthood inflammatory dietary pattern increased the risk of breast cancer in women.

In a recent study, researchers sought to determine if cholesterol lowering medication effected survival and recurrence outcomes in patients with breast cancer.

A new study found a correlation between the consumption of grilled meat and mortality rates in breast cancer survivors.

A recent study sought to identify factors affecting non-adherence to adjuvant endocrine treatment among women with breast cancer.